Insights This is a search field with an auto-suggest feature attached. There are no suggestions because the search field is empty. Careers Media Investors Contact us Company Company Purpose Strategy Leadership History Locations Offering Offering Drug Substances Exclusive synthesis API portfolio Reference standards Preclinical and early-phase development Alkaloid raw materials extraction Drug Products Oral solid dosage forms Sterile injectables Ophthalmics Inhalation products Viral vectors Technologies Sustainability Sustainability People Environment Integrity Quality Community engagement Risk management Insights What are you looking for? Company Purpose Strategy Leadership History Locations Offering Drug Substances Exclusive synthesis API portfolio Reference standards Preclinical and early-phase development Alkaloid raw materials extraction Drug Products Oral solid dosage forms Sterile injectables Ophthalmics Inhalation products Viral vectors Technologies Sustainability People Environment Integrity Quality Community engagement Risk management Insights Careers Media Investors Contact us Insights See our event recap Filter by tags Technology Early-phase development Sustainability Drug Products Oral solid dosage form Technology Early-phase development Sustainability Drug Products Oral solid dosage form Scale-up Regulatory support NEW 07/23/2026 Scale-up Drug Products Oral solid dosage form Dosage form scale-up: Balancing speed and efficiency in later-stage development Read article Recent Jul 8, 2026 Early-phase development Regulatory support Navigating the complex route to regulatory compliance, from preclinical to market Jun 22, 2026 Scale-up Drug Products The need for speed: Early-stage dosage form development Apr 2, 2026 Accelerate to win: The challenges of dosage form development Subscribe for more expert insights All posts Jul 23, 2026 Scale-up Drug Products Oral solid dosage form Dosage form scale-up: Balancing speed and efficiency in later-stage development Jul 8, 2026 Early-phase development Regulatory support Navigating the complex route to regulatory compliance, from preclinical to market Jun 22, 2026 Scale-up Drug Products Oral solid dosage form The need for speed: Early-stage dosage form development Apr 2, 2026 Accelerate to win: The challenges of dosage form development Mar 23, 2026 From lab to launch: Cutting time in pharmaceutical development Feb 20, 2026 Sustainability Sustainability is part of our daily business 1 2 3 4 5 Oct 30, 2025 Video: Insights from Chief Scientific Officer Stefan Randl at CPHI Frankfurt 2025 Sign up to stay up to date on Siegfried and our business performance. expect more Siegfried AG Untere Brühlstrasse 4 4800 Zofingen, Switzerland +41 62 746 11 11 Get in touch About us Our company Sustainability Media Investors Careers Helpful resources Expert insights News archive Reports Terms and conditions Offering Drug Substances Drug Products Technologies 2026 © Siegfried Holding AG Privacy Policy Legal disclaimer Imprint